Arginase in parasitic infections: Macrophage activation, immunosuppression, and intracellular signals

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Stempin, Cinthia C ^a   Dulgerian, Laura R ^a   Garrido, Vanina V ^a   Cerban, Fabio M ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; ARGINASE;

CELL PROLIFERATION; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME ACTIVITY; ENZYME INDUCTION; HELMINTHIASIS; HUMAN; IMMUNE RESPONSE; LEISHMANIASIS; MACROPHAGE ACTIVATION; NONHUMAN; PARASITE CLEARANCE; PARASITE SURVIVAL; PARASITEMIA; PARASITOSIS; PROTEIN EXPRESSION; PROTOZOAL INFECTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; ARTICLE; ENZYMOLOGY; HOST PARASITE INTERACTION; IMMUNOLOGY;

PROTOZOA;

ANIMALS; ARGINASE; HOST-PARASITE INTERACTIONS; HUMANS; MACROPHAGE ACTIVATION; PARASITIC DISEASES; SIGNAL TRANSDUCTION;

EID: 77449126859     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/683485     Document Type: Review

References (90)

1. M. Stein, S. Keshav, N. Harris, and S. Gordon, "Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation," Journal of Experimental Medicine, vol. 176, no. 1, pp. 287-292, 1992.
2. D. M. Mosser, "The many faces of macrophage activation," Journal of Leukocyte Biology, vol. 73, no. 2, pp. 209-212, 2003. (Pubitemid 36158295)
3. C. Nathan, "Mechanisms and modulation of macrophage activation," Behring Institut Mitteilungen, no. 88, pp. 200-207, 1991.
4. D. K. Dalton, S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart, "Multiple defects of immune cell function in mice with disrupted interferon-γ genes," Science, vol. 259, no. 5102, pp. 1739-1742, 1993. (Pubitemid 23114658)
5. S. Gordon, "Alternative activation of macrophages," Nature Reviews Immunology, vol. 3, no. 1, pp. 23-35, 2003. (Pubitemid 37328697)
6. F. S. Sutterwala, G. J. Noel, P. Salgame, and D. M. Mosser, "Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I," Journal of Experimental Medicine, vol. 188, no. 1, pp. 217-222, 1998. (Pubitemid 28328621)
7. C. F. Anderson and D. M. Mosser, "Cutting edge: biasing immune responses by directing antigen to macrophage Fcγ receptors," The Journal of Immunology, vol. 168, no. 8, pp. 3697-3701, 2002. (Pubitemid 34298366)
8. S. Goerdt and C. E. Orfanos, "Other functions, other genes: alternative activation of antigen-presenting cells," Immunity, vol. 10, no. 2, pp. 137-142, 1999. (Pubitemid 29115619)
9. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica, "Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes," Trends in Immunology, vol. 23, no. 11, pp. 549-555, 2002. (Pubitemid 35223554)
10. F. O. Martinez, L. Helming, and S. Gordon, "Alternative activation of macrophages: an immunologic functional perspective," Annual Review of Immunology, vol. 27, pp. 451-483, 2009.
11. F. O. Martinez, A. Sica, A. Mantovani, and M. Locati, "Macrophage activation and polarization," Frontiers in Bio-science, vol. 13, no. 2, pp. 453-461, 2008. (Pubitemid 351599757)
12. D. M. Mosser and J. P. Edwards, "Exploring the full spectrum of macrophage activation," Nature Reviews Immunology, vol. 8, no. 12, pp. 958-969, 2008.
13. R. D. Stout, C. Jiang, B. Matta, I. Tietzel, S. K. Watkins, and J. Suttles, "Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences," The Journal of Immunology, vol. 175, no. 1, pp. 342-349, 2005. (Pubitemid 40884337)
14. K. J. Mylonas, M. G. Nair, L. Prieto-Lafuente, D. Paape, and J. E. Allen, "Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing," The Journal of Immunology, vol. 182, no. 5, pp. 3084-3094, 2009.
15. C. Bogdan, "Nitric oxide and the immune response," Nature Immunology, vol. 2, no. 10, pp. 907-916, 2001. (Pubitemid 32976162)
16. J. MacMicking, Q.-W. Xie, and C. Nathan, "Nitric oxide and macrophage function," Annual Review of Immunology, vol. 15, pp. 323-350, 1997. (Pubitemid 27169284)
17. M. Modolell, I. M. Corraliza, F. Link, G. Soler, and K. Eichmann, "Reciprocal regulation of the nitric oxide synthase-arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines," European Journal of Immunology, vol. 25, no. 4, pp. 1101-1104, 1995.
18. P. Kropf, M. A. Freudenberg, M. Modolell, et al., "Tolllike receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major," Infection and Immunity, vol. 72, no. 4, pp. 1920-1928, 2004. (Pubitemid 38419902)
19. G. Peluffo, L. Piacenza, F. Irigoín, M. N. Alvarez, and R. Radi, "L-arginine metabolism during interaction of Trypanosoma cruzi with host cells," Trendsin Parasitology, vol. 20, no. 8, pp. 363-369, 2004. (Pubitemid 38916525)
20. M. Plebanski and A. V. S. Hill, "The immunology of malaria infection," Current Opinion in Immunology, vol. 12, no. 4, pp. 437-441, 2000. (Pubitemid 30410350)
21. M. Walther, J. Woodruff, F. Edele, et al., "Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes," The Journal of Immunology, vol. 177, no. 8, pp. 5736-5745, 2006. (Pubitemid 44527649)
22. W. Noël, Gh. Hassanzadeh, G. Raes, et al., "Infection stage-dependent modulation of macrophage activation in Tr y-panosoma congolense-resistant and-susceptible mice," Infection and Immunity, vol. 70, no. 11, pp. 6180-6187, 2002. (Pubitemid 35192709)
23. F. M. Omer, J. B. de Souza, and E. M. Riley, "Differential induction of TGF-β regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections," The Journal of Immunology, vol. 171, no. 10, pp. 5430-5436, 2003. (Pubitemid 37432830)
24. + T cells correlates with Th1/Th2 phenotype," The Journal of Immunology, vol. 160, no. 11, pp. 5347-5354, 1998. (Pubitemid 28267823)
25. M. Hesse, M. Modolell, A. C. La Flamme, et al., "Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism," The Journal of Immunology, vol. 167, no. 11, pp. 6533-6544, 2001. (Pubitemid 33081589)
26. C. G. Freire-De-Lima, D. O. Nascimento, M. B. P. Soares, et al., "Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages," Nature, vol. 403, no. 6766, pp. 199-203, 2000. (Pubitemid 30050963)
27. B. Mues, D. Langer, G. Zwadlo, and C. Sorg, "Phenotypic characterization of macrophages in human term placenta," Immunology, vol. 67, no. 3, pp. 303-307, 1989. (Pubitemid 19178845)
28. P. Kropf, D. Baud, S. E. Marshall, et al., "Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy," European Journal of Immunology, vol. 37, no. 4, pp. 935-945, 2007. (Pubitemid 46925331)
29. -) in psoriatic dermis," Archives of Dermatological Research, vol. 288, no. 12, pp. 757-764, 1996. (Pubitemid 26388134)
30. S. Goerdt, R. Bhardwaj, and C. Sorg, "Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro," American Journal of Pathology, vol. 142, no. 5, pp. 1409-1422, 1993. (Pubitemid 24058128)
31. W. Noël, G. Raes, G. H. Ghassabeh, P. De Baetselier, and A. Beschin, "Alternatively activated macrophages during parasite infections," Trends in Parasitology, vol. 20, no. 3, pp. 126-133, 2004. (Pubitemid 38264445)
32. G. Raes, A. Beschin, G. H. Ghassabeh, and P. De Baetselier, "Alternatively activated macrophages in protozoan infections," Current Opinion in Immunology, vol. 19, no. 4, pp. 454-459, 2007. (Pubitemid 47284853)
33. L. Brys, A. Beschin, G. Raes, et al., "Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection," The Journal of Immunology, vol. 174, no. 10, pp. 6095-6104, 2005. (Pubitemid 40663798)
34. J. L. Reyes and L. I. Terrazas, "The divergent roles of alternatively activated macrophages in helminthic infections," Parasite Immunology, vol. 29, no. 12, pp. 609-619, 2007. (Pubitemid 350179388)
35. M. Rodróguez-Sosa, A. R. Satoskar, R. Calderón, et al., "Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability," Infection and Immunity, vol. 70, no. 7, pp. 3656-3664, 2002.
36. L. I. Terrazas, D. Montero, C. A. Terrazas, J. L. Reyes, and M. Rodróguez-Sosa, "Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis," International Journal for Parasitology, vol. 35, no. 13, pp. 1349-1358, 2005. (Pubitemid 41484148)
37. P. Loke, A. S. MacDonald, A. Robb, R. M. Maizels, and J. E. Allen, "Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact," European Journal of Immunology, vol. 30, no. 9, pp. 2669-2678, 2000.
38. S. Dissanayake, N. Khan, A. Shahin, S. Wijesinghe, and M. Lukic, "Induction of immunoglobulin G1, interleukin-6 and interleukin-10 by Taenia crassiceps metacestode carbohydrates," Immunology, vol. 107, no. 4, pp. 411-419, 2002. (Pubitemid 36693645)
39. M. Rodróguez-Sosa, I. Rivera-Montoya, A. Espinoza, et al., "Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages," Cellular Immunology, vol. 242, no. 2, pp. 61-71, 2006. (Pubitemid 46496968)
40. L. R. Brunet, M. Beall, D. W. Dunne, and E. J. Pearce, "Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection," The Journal of Immunology, vol. 163, no. 9, pp. 4976-4984, 1999. (Pubitemid 29501265)
41. L. R. Brunet, F. D. Finkelman, A. W. Cheever, M. A. Kopf, and E. J. Pearce, "IL-4 protects against TNF-α-mediated cachexia and death during acute schistosomiasis," The Journal of Immunology, vol. 159, no. 2, pp. 777-785, 1997. (Pubitemid 127484229)
42. E. J. Pearce and A. S. MacDonald, "The immunobiology of schistosomiasis," Nature Reviews Immunology, vol. 2, no. 7, pp. 499-511, 2002. (Pubitemid 37328741)
43. T. A. Wynn, R. W. Thompson, A. W. Cheever, and M. M. Mentink-Kane, "Immunopathogenesis of schistosomiasis," Immunological Reviews, vol. 201, pp. 156-167, 2004. (Pubitemid 39318450)
44. O. M. S. Abdallahi, H. Bensalem, R. Augier, M. Daigana, M. De Reggi, and B. Gharib, "Arginase expression in peritoneal macrophages and increase in circulating polyamine levels in mice infected with Schistosoma mansoni" Cellular and Molecular Life Sciences, vol. 58, no. 9, pp. 1350-1357, 2001. (Pubitemid 32844105)
45. D. R. Herbert, C. Hölscher, M. Mohrs, et al., "Alternative macrophage activation is essential for survival during schis-tosomiasis and downmodulates T helper 1 responses and immunopathology," Immunity, vol. 20, no. 5, pp. 623-635, 2004. (Pubitemid 38659504)
46. J. T. Pesce, T. R. Ramalingam, M. M. Mentink-Kane, et al., "Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis," PLoS Pathogens, vol. 5, no. 4, Article ID e1000371, 15 pages, 2009.
47. M. G. Nair, Y. Du, J. G. Perrigoue, et al., "Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung," Journal of Experimental Medicine, vol. 206, no. 4, pp. 937-952, 2009.
48. R. M. Anthony, J. F. Urban, F. Alem, et al., "Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites," Nature Medicine, vol. 12, no. 8, pp. 955-960, 2006. (Pubitemid 44175149)
49. A. Zhao, J. McDermott, J. F. Urban Jr., et al., "Dependence of IL-4, IL-13, and nematode-induced alterations in murine small intestinal smooth muscle contractility on Stat6 and enteric nerves," The Journal of Immunology, vol. 171, no. 2, pp. 948-954, 2003. (Pubitemid 36871409)
50. T. Shea-Donohue, C. Sullivan, F. D. Finkelman, et al., "The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function," The Journal of Immunology, vol. 167, no. 4, pp. 2234-2239, 2001. (Pubitemid 32747535)
51. A. Zhao, J. F. Urban Jr., R. M. Anthony, et al., "Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages," Gastroen-terology, vol. 135, no. 1, pp. 217-225, 2008.
52. P. Baetselier, B. Namangala, W. Noel, L. Brys, E. Pays, and A. Beschin, "Alternative versus classical macrophage activation during experimental African trypanosomosis," International Journal for Parasitology, vol. 31, no. 5-6, pp. 575-587, 2001. (Pubitemid 32382058)
53. T. Scharton-Kersten, L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott, "IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental Leishmaniasis," The Journal of Immunology, vol. 154, no. 10, pp. 5320-5330, 1995.
54. V. Iniesta, J. Carcelén, I. Molano, et al., "Arginase I induction during Leishmania major infection mediates the development of disease," Infection and Immunity, vol. 73, no. 9, pp. 6085-6090, 2005. (Pubitemid 41193047)
55. P. Kropf J. M. Fuentes, E. Fähnrich, et al., "Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo," The FASEB Journal, vol. 19, no. 8, pp. 1000-1002, 2005. (Pubitemid 40827731)
56. ω-hydroxy-L-arginine controls the growth of Leishmania inside macrophages," Journal of Experimental Medicine, vol. 193, no. 6, pp. 777-783, 2001. (Pubitemid 32524470)
57. C. Ḧelscher, B. Arendse, A. Schwegmann, E. Myburgh, and F. Brombacher, "Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice," The Journal of Immunology, vol. 176, no. 2, pp. 1115-1121, 2006. (Pubitemid 43099713)
58. V. Michailowsky, N. M. Silva, C. D. Rocha, L. Q. Vieira, J. Lannes-Vieira, and R. T. Gazzinelli, "Pivotal role of interleukin-12 and interferon-γ axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection," American Journal of Pathology, vol. 159, no. 5, pp. 1723-1733, 2001. (Pubitemid 33062515)
59. M. M. Rodrigues, M. Ribeiräo, and S. B. Boscardin, "CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism," Immunology Letters, vol. 73, no. 1, pp. 43-50, 2000. (Pubitemid 30645566)
60. I. A. Abrahamsohn, A. P. G. da Silva, and R. L. Coffman, "Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi," Infection and Immunity, vol. 68, no. 4, pp. 1975-1979, 2000. (Pubitemid 30164826)
61. C. Hëlscher, M. Mohrs, W. J. Dai, et al., "Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice," Infection and Immunity, vol. 68, no. 7, pp. 4075-4083, 2000. (Pubitemid 30434562)
62. L. Giordanengo, N. Guiñazú, C. Stempin, R. Fretes, F. Cerbán, and S. Gea, "Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite," European Journal of Immunology, vol. 32, no. 4, pp. 1003-1011, 2002. (Pubitemid 34428815)
63. C. Stempin, L. Giordanengo, S. Gea, and F. Cerbán, "Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen," Journal of Leukocyte Biology, vol. 72, no. 4, pp. 727-734, 2002. (Pubitemid 36277844)
64. C. C. Stempin, T. B. Tanos, O. A. Coso, and F. M. Cerbán, "Arginase induction promotes Trypanosoma cruzi intracellular replication of Cruzipain-treated J774 cells through the activation of multiple signaling pathways," European Journal of Immunology, vol. 34, no. 1, pp. 200-209, 2004. (Pubitemid 38111536)
65. D. L. Fabrino, L. L. Leon, G. G. Parreira, M. Genestra, P. E. Almeida, and R. C. N. Melo, "Peripheral blood monocytes show morphological pattern of activation and decreased nitric oxide production during acute Chagas' disease in rats," Nitric Oxide, vol. 11, no. 2, pp. 166-174, 2004. (Pubitemid 39371094)
66. L. Piacenza, G. Peluffo, and R. Radi, "L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: contribution of the nitric oxide and polyamine pathways," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 13, pp. 7301-7306, 2001. (Pubitemid 32567943)
67. P. Loke, M. G. Nair, J. Parkinson, D. Guiliano, M. Blaxter, and J. E. Allen, "IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype," BMC Immunology, vol. 3, article 7, pp. 1-11, 2002.
68. G. Raes, P. De Baetselier, W. Noël, A. Beschin, F. Brombacher, and H. G. Gholamreza, "Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages," Journal of Leukocyte Biology, vol. 71, no. 4, pp. 597-602, 2002.
69. G. Raes, W. Noël, A. Beschin, L. Brys, P. De Baetselier, and Gh. Hassanzadeh, "FIZZ1 and Ym as tools to discriminate between differentially activated macrophages," Developmental Immunology, vol. 9, no. 3, pp. 151-159, 2002. (Pubitemid 36898373)
70. G. Raes, R. Van den Bergh, P. De Baetselier, et al., "Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells," The Journal of Immunology, vol. 174, no. 11, pp. 6561-6562, 2005. (Pubitemid 40705613)
71. S. Babu, V. Kumaraswami, and T. B. Nutman, "Alternatively activated and immunoregulatory monocytes in human filarial infections," Journal of Infectious Diseases, vol. 199, no. 12, pp. 1827-1837, 2009.
72. A. L. Scott, "The alternatively activated human-redux," Journal of Infectious Diseases, vol. 199, no. 12, pp. 1723-1725, 2009.
73. M. Munder, F. Mollinedo, J. Calafat, et al., "Arginase I is con-stitutively expressed in human granulocytes and participates in fungicidal activity," Blood, vol. 105, no. 6, pp. 2549-2556, 2005. (Pubitemid 40387058)
74. M. Munder, H. Schneider, C. Luckner, et al., "Suppression of T-cell functions by human granulocyte arginase," Blood, vol. 108, no. 5, pp. 1627-1634, 2006. (Pubitemid 44316131)
75. P. Kropf, D. Baud, S. E. Marshall, et al., "Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy," European Journal of Immunology, vol. 37, no. 4, pp. 935-945, 2007. (Pubitemid 46925331)
76. V. Bronte and P. Zanovello, "Regulation of immune responses by L-arginine metabolism," Nature Reviews Immunology, vol. 5, no. 8, pp. 641-654, 2005. (Pubitemid 41113195)
77. M. Modolell, B. S. Choi, R. O. Ryan, et al., "Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis," PLoS Neglected Tropical Diseases, vol. 3, no. 7, article e480, 2009.
78. Y. Latchman, C. R. Wood, T. Chernova, et al., "PD-L2 is a second ligand for PD-1 and inhibits T cell activation," Nature Immunology, vol. 2, no. 3, pp. 261-268, 2001. (Pubitemid 33706004)
79. Y. E. Latchman, S. C. Liang, Y. Wu, et al., "PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10691-10696, 2004. (Pubitemid 38955804)
80. P. Smith, C. M. Walsh, N. E. Mangan, et al., "Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages," The Journal of Immunology, vol. 173, no. 2, pp. 1240-1248, 2004. (Pubitemid 38924302)
81. F. Kierszenbaum, M. B. Sztein, and L. A. Beltz, "Decreased human IL-2 receptor expression due to a protozoan pathogen," Trends in Immunology, vol. 10, no. 4, pp. 129-131, 1989. (Pubitemid 19074171)
82. Y. Liu, Y. Yu, S. Yang, et al., "Regulation of arginase i activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells," Cancer Immunology, Immunother-apy, vol. 58, no. 5, pp. 687-697, 2009.
83. J. Oberlies, C. Watzl, T. Giese, et al., "Regulation of NK cell function by human granulocyte arginase," The Journal of Immunology, vol. 182, no. 9, pp. 5259-5267, 2009.
84. I. M. Corraliza, M. Modolell, E. Ferber, and G. Soler, "Involvement of protein kinase A in the induction of arginase in murine bone marrow-derived macrophages," Biochimica et Biophysica Acta, vol. 1334, no. 2-3, pp. 123-128, 1997. (Pubitemid 27117513)
85. C.-I. Chang, B. Zoghi, J. C. Liao, and L. Kuo, "The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production," The Journal of Immunology, vol. 165, no. 4, pp. 2134-2141, 2000. (Pubitemid 30643163)
86. I. Haffner, D. Teupser, L. M. Holdt, J. Ernst, R. Burkhardt, and J. Thiery, "Regulation of arginase-1 expression in macrophages by a protein kinase A type I and histone deacetylase dependent pathway," Journal of Cellular Biochemistry, vol. 103, no. 2, pp. 520-527, 2008. (Pubitemid 351171922)
87. C. C. Stempin, V. V. Garrido, L. R. Dulgerian, and F. M. Cerbán, "Cruzipain and SP600125 induce p38 activation, alter NO/arginase balance and favor the survival of Trypanosoma cruzi in macrophages," Acta Tropica, vol. 106, no. 2, pp. 119-127, 2008.
88. A.-L. Pauleau, R. Rutschman, R. Lang, A. Pernis, S. S. Watowich, and P. J. Murray, "Enhancer-mediated control of macrophage-specific arginase I expression," The Journal of Immunology, vol. 172, no. 12, pp. 7565-7573, 2004. (Pubitemid 38747620)
89. R. Rutschman, R. Lang, M. Hesse, J. N. Ihle, T. A. Wynn, and P. J. Murray, "Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production," The Journal of Immunology, vol. 166, no. 4, pp. 2173-2177, 2001. (Pubitemid 32173445)
90. K. C. El Kasmi, J. E. Qualls, J. T. Pesce, et al., "Tolllike receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens," Nature Immunology, vol. 9, no. 12, pp. 1399-1406, 2008.